Sorrento Therapeutics, Inc. (SRNE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.7000 |
| Open | 2.6800 |
| Bid | 2.7400 x 21500 |
| Ask | 2.7800 x 2200 |
| Day's range | 2.6400 - 2.8000 |
| 52-week range | 1.1500 - 9.6300 |
| Volume | |
| Avg. volume | 10,417,559 |
| Market cap | 1.073B |
| Beta (5Y monthly) | 2.21 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Sorrento (SRNE) Rises on FDA IND Clearance for COVID Drug
Sorento Therapeutics (SRNE) receives IND application clearance from the FDA for a phase I study evaluating STI-1558 for COVID-19.
- Motley Fool
Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today
The back half of 2022 is already shaping up to be a stock picker's market. Today's mixed trading session in the volatile healthcare sector is a case in point. For example, shares of the clinical-stage biotech Ocugen (NASDAQ: OCGN) were down by a hefty 9.5% and Sorrento Therapeutics' (NASDAQ: SRNE) equity was in the red by 5.62% at 11:02 a.m. ET Thursday.
- Simply Wall St.
What Kind Of Investors Own Most Of Sorrento Therapeutics, Inc. (NASDAQ:SRNE)?
The big shareholder groups in Sorrento Therapeutics, Inc. ( NASDAQ:SRNE ) have power over the company. Large companies...
© 2022 Yahoo. All rights reserved.
